MCHP earnings

MICROCHIP TECHNOLOGY INC reported Q1 FY2027. EPS came in at $0.76 against a $0.70 consensus, beat by 8.6%. Revenue was $1.5B versus $1.5B expected, beat by 1.8%. Gross margin was 63.2%, up 220 bps from last quarter.

MICROCHIP TECHNOLOGY INC delivered only a small Street revenue beat, but the investable surprise is that distributor normalization and underutilization relief are arriving early enough to make the March margin guide more credible than the stock’s cycle-scarred setup likely allowed. The market was priced for a fragile analog and embedded controller recovery; the print says the recovery is still shallow on sales, but the earnings power trough is already behind it if sell-in stays close to sell-through and the $50 million underutilization drag begins to fade.

MICROCHIP TECHNOLOGY INC printed only a +0.7% revenue surprise, but the actionable signal is that EPS beat by +5.9% while management guided gross margin higher despite December-quarter sales guided down 1% sequentially at the midpoint. The market likely came in pricing a cyclical bottom; the variant view is that the recovery in earnings power is arriving before the revenue recovery, because underutilization and inventory charges are no longer worsening.

MICROCHIP TECHNOLOGY INC cleared a low bar with EPS upside of +13.0% and revenue upside of +1.7%, but the actionable point is that product gross margin is already back near the long-term model once inventory and underutilization charges are stripped out. The market may be overpricing the cyclical rebound in near-term sales and underpricing the operating leverage embedded in falling charges, restrained capex, and a supply chain that is only beginning to tighten.